{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:49:21Z","timestamp":1791362961739,"version":"4.3.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>We lack specific treatments for traumatic brain injury (TBI), which remains the leading cause of trauma-related morbidity and mortality. Treatment with valproic acid (VPA) improves outcomes in models of severe TBI with concurrent hemorrhage. However, it is unknown if VPA will have similar benefits after isolated nonlethal TBI, which is the more common clinical scenario. The goal of this study was to evaluate the effect of VPA treatment in a preclinical isolated TBI swine model on neurologic outcomes and brain lesion size and to perform detailed pharmacokinetic analyses for a future clinical trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Yorkshire swine (n = 10; 5\/cohort) were subjected to TBI (8-mm controlled cortical impact). An hour later, we randomized them to receive VPA (150 mg\/kg) or saline placebo (control). Neuroseverity scores were assessed daily (0 [normal] to 36 [comatose]), brain lesion size was measured on postinjury 3, and serial blood samples were collected for pharmacokinetic studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Physiologic parameters and laboratory values were similar in both groups. Valproic acid\u2013treated animals demonstrated significantly better neuroseverity scores on postinjury 1 (control, 9.2 \u00b1 4.4; VPA, 0 \u00b1 0; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001). Valproic acid\u2013treated animals had significantly smaller brain lesion sizes (mean volume in microliter: control, 3,130 \u00b1 2,166; VPA, 764 \u00b1 208; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.02). Pharmacokinetic data confirmed adequate plasma and tissue levels of VPA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>In this clinically relevant model of isolated TBI, a single dose of VPA attenuates neurological impairment and decreases brain lesion size.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ta.0000000000003136","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T02:15:37Z","timestamp":1614392137000},"page":"867-871","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["A single dose of valproic acid improves neurologic recovery and decreases brain lesion size in swine subjected to an isolated traumatic brain injury"],"prefix":"10.1097","volume":"91","author":[{"given":"Glenn K.","family":"Wakam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben E.","family":"Biesterveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath P.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishani K.","family":"Rajanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiril","family":"Chtraklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire A.","family":"Vercruysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan B.","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib2-20250806","first-page":"1","article-title":"Estimating the global incidence of traumatic brain injury","year":"2018","journal-title":"J Neurosurg"},{"issue":"5","key":"bib3-20250806","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.apmr.2013.10.032","article-title":"Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain","volume":"95","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"bib4-20250806","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/TA.0000000000002460","article-title":"Dose optimization of valproic acid in a lethal model of traumatic brain injury, hemorrhage, and multiple trauma in swine","volume":"87","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"bib5-20250806","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TA.0000000000001612","article-title":"Valproic acid decreases brain lesion size and improves neurologic recovery in swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma","volume":"83","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"bib6-20250806","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/TA.0000000000000789","article-title":"Addition of low-dose valproic acid to saline resuscitation provides neuroprotection and improves longterm outcomes in a large animal model of combined traumatic brain injury and hemorrhagic shock","volume":"79","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"bib7-20250806","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/TA.0000000000003036","article-title":"Administration of valproic acid in clinically approved dose improves neurologic recovery and decreases brain lesion size in swine subjected to hemorrhagic shock and traumatic brain injury","volume":"90","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"bib8-20250806","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/TA.0b013e3182782675","article-title":"Patients with severe traumatic brain injury transferred to a level I or II trauma center: United States, 2007 to 2009","volume":"73","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"bib9-20250806","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.surg.2013.05.008","article-title":"Synergistic effects of fresh frozen plasma and valproic acid treatment in a combined model of traumatic brain injury and hemorrhagic shock","volume":"154","year":"2013","journal-title":"Surgery"},{"issue":"5","key":"bib10-20250806","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jamcollsurg.2015.01.057","article-title":"Early resuscitation with fresh frozen plasma for traumatic brain injury combined with hemorrhagic shock improves neurologic recovery","volume":"220","year":"2015","journal-title":"J Am Coll Surg"},{"issue":"3","key":"bib11-20250806","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00005373-200003000-00011","article-title":"Induced hypothermia during emergency department thoracotomy: an animal model","volume":"48","year":"2000","journal-title":"J Trauma"},{"issue":"6","key":"bib12-20250806","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/TA.0b013e3182782641","article-title":"Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury","volume":"73","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"bib13-20250806","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1471-4159.1985.tb08793.x","article-title":"Blood-brain barrier transport of valproic acid","volume":"44","year":"1985","journal-title":"J Neurochem"},{"issue":"1","key":"bib14-20250806","first-page":"13","article-title":"Valproate serum concentrations in patients with hypoalbuminemia and medical complications","volume":"7","year":"2018","journal-title":"Ment Health Clin"},{"issue":"4","key":"bib15-20250806","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/FTD.0000000000000749","article-title":"Prediction of serum-free and cerebrospinal fluid valproic acid levels in patients with hypoalbuminemia after craniotomy","volume":"42","year":"2020","journal-title":"Ther Drug Monit"},{"issue":"2","key":"bib16-20250806","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12028-018-0627-4","article-title":"Accuracy of valproic acid concentration correction based on serum albumin","volume":"30","year":"2019","journal-title":"Neurocrit Care"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:12:45Z","timestamp":1754496765000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000003136","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}